Autonomix Medical (AMIX) Competitors

$0.32 -0.01 (-2.25%)

Closing price 05/14/2026 04:00 PM Eastern

Extended Trading

$0.32 0.00 (-0.03%)

As of 07:00 AM Eastern

AMIX vs. MBAI, ALUR, SINT, VVOS, and TNON

Should you buy Autonomix Medical stock or one of its competitors? MarketBeat compares Autonomix Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Autonomix Medical include Check-Cap (MBAI), Allurion Technologies (ALUR), Sintx Technologies (SINT), Vivos Therapeutics (VVOS), and Tenon Medical (TNON). These companies are all part of the "medical equipment" industry.

How does Autonomix Medical compare to Check-Cap?

Autonomix Medical (NASDAQ:AMIX) and Check-Cap (NASDAQ:MBAI) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

Check-Cap's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-228.82%	-186.65%
Check-Cap	N/A	N/A	N/A

Autonomix Medical has a beta of -1.82, indicating that its stock price is 282% less volatile than the broader market. Comparatively, Check-Cap has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Check-Cap is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41M	-$3.55	N/A
Check-Cap	N/A	N/A	$4.14M	-$2.77	N/A

Autonomix Medical presently has a consensus target price of $2.00, suggesting a potential upside of 520.93%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Check-Cap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Autonomix Medical and Autonomix Medical both had 1 articles in the media. Autonomix Medical's average media sentiment score of 1.89 beat Check-Cap's score of 1.87 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Autonomix Medical	Very Positive
Check-Cap	Very Positive

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 0.5% of Check-Cap shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Autonomix Medical beats Check-Cap on 7 of the 12 factors compared between the two stocks.

How does Autonomix Medical compare to Allurion Technologies?

Autonomix Medical (NASDAQ:AMIX) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

In the previous week, Allurion Technologies had 1 more articles in the media than Autonomix Medical. MarketBeat recorded 2 mentions for Allurion Technologies and 1 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 1.89 beat Allurion Technologies' score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Autonomix Medical	Very Positive
Allurion Technologies	Neutral

Autonomix Medical has a beta of -1.82, indicating that its stock price is 282% less volatile than the broader market. Comparatively, Allurion Technologies has a beta of -0.18, indicating that its stock price is 118% less volatile than the broader market.

Autonomix Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -199.96%. Allurion Technologies' return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-228.82%	-186.65%
Allurion Technologies	-199.96%	N/A	-77.13%

Allurion Technologies has higher revenue and earnings than Autonomix Medical. Allurion Technologies is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41M	-$3.55	N/A
Allurion Technologies	$17.21M	0.88	-$7.20M	-$10.56	N/A

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 8.1% of Allurion Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Autonomix Medical presently has a consensus target price of $2.00, suggesting a potential upside of 520.93%. Allurion Technologies has a consensus target price of $3.00, suggesting a potential upside of 197.03%. Given Autonomix Medical's higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Allurion Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Allurion Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Allurion Technologies beats Autonomix Medical on 8 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to Sintx Technologies?

Autonomix Medical (NASDAQ:AMIX) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

In the previous week, Autonomix Medical and Autonomix Medical both had 1 articles in the media. Autonomix Medical's average media sentiment score of 1.89 beat Sintx Technologies' score of 0.93 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Autonomix Medical	Very Positive
Sintx Technologies	Positive

Autonomix Medical has a beta of -1.82, indicating that its share price is 282% less volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market.

Autonomix Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,018.08%. Autonomix Medical's return on equity of -228.82% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-228.82%	-186.65%
Sintx Technologies	-1,018.08%	-242.76%	-99.86%

Sintx Technologies has higher revenue and earnings than Autonomix Medical. Sintx Technologies is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41M	-$3.55	N/A
Sintx Technologies	$1.02M	9.69	-$10.36M	-$5.66	N/A

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by company insiders. Comparatively, 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Autonomix Medical presently has a consensus target price of $2.00, suggesting a potential upside of 520.93%. Sintx Technologies has a consensus target price of $11.00, suggesting a potential upside of 358.33%. Given Autonomix Medical's higher probable upside, equities analysts clearly believe Autonomix Medical is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Autonomix Medical and Sintx Technologies tied by winning 7 of the 14 factors compared between the two stocks.

How does Autonomix Medical compare to Vivos Therapeutics?

Autonomix Medical (NASDAQ:AMIX) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

In the previous week, Vivos Therapeutics had 2 more articles in the media than Autonomix Medical. MarketBeat recorded 3 mentions for Vivos Therapeutics and 1 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 1.89 beat Vivos Therapeutics' score of 0.72 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Autonomix Medical	Very Positive
Vivos Therapeutics	Positive

Autonomix Medical has a beta of -1.82, indicating that its share price is 282% less volatile than the broader market. Comparatively, Vivos Therapeutics has a beta of 6.25, indicating that its share price is 525% more volatile than the broader market.

Autonomix Medical has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -121.37%. Autonomix Medical's return on equity of -228.82% beat Vivos Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-228.82%	-186.65%
Vivos Therapeutics	-121.37%	-849.22%	-96.11%

Autonomix Medical has higher earnings, but lower revenue than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41M	-$3.55	N/A
Vivos Therapeutics	$17.44M	0.54	-$21.17M	-$2.07	N/A

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by company insiders. Comparatively, 2.1% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Autonomix Medical presently has a consensus target price of $2.00, suggesting a potential upside of 520.93%. Vivos Therapeutics has a consensus target price of $2.58, suggesting a potential upside of 274.40%. Given Autonomix Medical's higher probable upside, equities analysts clearly believe Autonomix Medical is more favorable than Vivos Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vivos Therapeutics	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Vivos Therapeutics beats Autonomix Medical on 8 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Tenon Medical?

Tenon Medical (NASDAQ:TNON) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

Autonomix Medical has a net margin of 0.00% compared to Tenon Medical's net margin of -270.09%. Autonomix Medical's return on equity of -228.82% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-270.09%	-560.04%	-115.53%
Autonomix Medical	N/A	-228.82%	-186.65%

Tenon Medical has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.82, indicating that its stock price is 282% less volatile than the broader market.

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 0.3% of Tenon Medical shares are owned by insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Tenon Medical had 5 more articles in the media than Autonomix Medical. MarketBeat recorded 6 mentions for Tenon Medical and 1 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 1.89 beat Tenon Medical's score of -0.04 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Tenon Medical	Neutral
Autonomix Medical	Very Positive

Autonomix Medical has a consensus target price of $2.00, suggesting a potential upside of 520.93%. Given Autonomix Medical's higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Autonomix Medical has lower revenue, but higher earnings than Tenon Medical. Tenon Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.94M	2.08	-$12.56M	-$1.99	N/A
Autonomix Medical	N/A	N/A	-$11.41M	-$3.55	N/A

Summary

Autonomix Medical beats Tenon Medical on 7 of the 13 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMIX vs. The Competition

Export

Metric	Autonomix Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.28M	$6.81B	$6.34B	$12.37B
Dividend Yield	N/A	1.74%	2.80%	5.35%
P/E Ratio	-0.09	50.22	20.66	25.63
Price / Sales	N/A	73.63	547.76	76.59
Price / Cash	N/A	24.26	43.26	56.33
Price / Book	0.10	6.61	9.88	6.97
Net Income	-$11.41M	$158.34M	$3.55B	$333.62M
7 Day Performance	-7.97%	-1.17%	1.69%	1.09%
1 Month Performance	-20.21%	-3.01%	0.48%	3.08%
1 Year Performance	-83.05%	-2.36%	39.39%	35.68%

Autonomix Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMIX Autonomix Medical	2.878 of 5 stars	$0.32 -2.2%	$2.00 +520.9%	-81.5%	$2.28M	N/A	N/A	1	Gap Down
MBAI Check-Cap	0.6743 of 5 stars	$1.43 flat	N/A	N/A	$10.43M	N/A	N/A	80	Positive News
ALUR Allurion Technologies	1.3225 of 5 stars	$0.68 -1.1%	$3.00 +341.2%	-67.0%	$10.20M	$17.21M	N/A	501
SINT Sintx Technologies	3.502 of 5 stars	$2.40 -0.8%	$11.00 +358.3%	-30.4%	$9.89M	$1.02M	N/A	40	Gap Up High Trading Volume
VVOS Vivos Therapeutics	3.3179 of 5 stars	$0.72 +1.5%	$2.58 +258.8%	-77.3%	$9.80M	$17.44M	N/A	160	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMIX) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Autonomix Medical (AMIX) Competitors

AMIX vs. MBAI, ALUR, SINT, VVOS, and TNON

How does Autonomix Medical compare to Check-Cap?

Summary

How does Autonomix Medical compare to Allurion Technologies?

Summary

How does Autonomix Medical compare to Sintx Technologies?

Summary

How does Autonomix Medical compare to Vivos Therapeutics?

Summary

How does Autonomix Medical compare to Tenon Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Autonomix Medical (AMIX) Competitors

AMIX vs. MBAI, ALUR, SINT, VVOS, and TNON

How does Autonomix Medical compare to Check-Cap?

Is AMIX or MBAI more profitable?

Which has more volatility & risk, AMIX or MBAI?

Which has higher earnings & valuation, AMIX or MBAI?

Do analysts rate AMIX or MBAI?

Does the media refer more to AMIX or MBAI?

Do insiders and institutionals have more ownership in AMIX or MBAI?

Summary

How does Autonomix Medical compare to Allurion Technologies?

Does the media refer more to AMIX or ALUR?

Which has more volatility & risk, AMIX or ALUR?

Is AMIX or ALUR more profitable?

Which has higher earnings & valuation, AMIX or ALUR?

Do insiders and institutionals have more ownership in AMIX or ALUR?

Do analysts rate AMIX or ALUR?

Summary

How does Autonomix Medical compare to Sintx Technologies?

Does the media prefer AMIX or SINT?

Which has more risk & volatility, AMIX or SINT?

Is AMIX or SINT more profitable?

Which has better earnings and valuation, AMIX or SINT?

Do institutionals and insiders have more ownership in AMIX or SINT?

Do analysts recommend AMIX or SINT?

Summary

How does Autonomix Medical compare to Vivos Therapeutics?

Does the media prefer AMIX or VVOS?

Which has more risk & volatility, AMIX or VVOS?

Is AMIX or VVOS more profitable?

Which has better earnings and valuation, AMIX or VVOS?

Do institutionals and insiders have more ownership in AMIX or VVOS?

Do analysts recommend AMIX or VVOS?

Summary

How does Autonomix Medical compare to Tenon Medical?

Is TNON or AMIX more profitable?

Which has more risk & volatility, TNON or AMIX?

Do insiders & institutionals hold more shares of TNON or AMIX?

Does the media favor TNON or AMIX?

Do analysts prefer TNON or AMIX?

Which has stronger valuation and earnings, TNON or AMIX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools